Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Raw Materials (2018 - 2025)

Historic Raw Materials for Jaguar Health (JAGX) over the last 8 years, with Q3 2025 value amounting to $2.0 million.

  • Jaguar Health's Raw Materials rose 484.21% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 484.21%. This contributed to the annual value of $1.8 million for FY2024, which is 1006.32% down from last year.
  • Jaguar Health's Raw Materials amounted to $2.0 million in Q3 2025, which was up 484.21% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Raw Materials registered a high of $2.2 million during Q1 2024, and its lowest value of $701000.0 during Q2 2021.
  • Its 5-year average for Raw Materials is $1.8 million, with a median of $1.9 million in 2025.
  • As far as peak fluctuations go, Jaguar Health's Raw Materials skyrocketed by 17845.93% in 2022, and later plummeted by 1457.77% in 2025.
  • Quarter analysis of 5 years shows Jaguar Health's Raw Materials stood at $1.2 million in 2021, then soared by 68.35% to $2.1 million in 2022, then fell by 2.09% to $2.1 million in 2023, then decreased by 10.06% to $1.8 million in 2024, then grew by 7.68% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $1.9 million for Q2 2025, and $1.9 million during Q1 2025.